VOYA Investment Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
Other funds holding ZNTL
MCMC
OM
AC
TCM
TCM
VOYA Investment Management's ZNTL Position: Q2 2025 in Review
VOYA Investment Management sold out of Zentalis Pharmaceuticals (ZNTL) in Q2 2025, closing a stake of 17,282 shares — an estimated $27.5K sold.
VOYA Investment Management first reported a position in ZNTL in Q4 2020 and held it in 18 quarters. The position peaked at $3M in Q2 2023. 117 funds tracked by Wall St. Rank hold ZNTL as of Q2 2025.
- VOYA Investment Management reported no remaining Zentalis Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
- VOYA Investment Management sold 17,282 Zentalis Pharmaceuticals shares in Q2 2025, an estimated $27.5K.
- VOYA Investment Management first reported a position in Zentalis Pharmaceuticals in Q4 2020 and held it in 18 quarters.
- VOYA Investment Management's Zentalis Pharmaceuticals position peaked at $3M in Q2 2023.
- 117 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q2 2025.
Based on VOYA Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.